Public annual accounts

Pharmacie de la Reffe financials

Name: Pharmacie de la Reffe financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Pharmacie de la Reffe, with comparable measures and links to available source documents.

Company overview

Registry number

0463249234

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Pharmacie de la Reffe

2025 versus 2024

Operating line: €391,786
EBITDA: €218,855
Total assets: €773,427
Equity: €448,820

EBITDA margin +55.9% · Equity ratio +58%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€391,786	€218,855	€773,427	€448,820	-
202431 Dec 2024	€261,439	€40,186	€830,275	€343,161	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€391,786

€218,855

€773,427

€448,820

202431 Dec 2024

€261,439

€40,186

€830,275

€343,161